FDA Inspection
Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. – FDA Inspection, Sep 30, 2021
Record Details
This FDA Inspection record concerns Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A., with an inspection on September 30, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 30, 2021
- Product Type
- Drugs
View Company Profile
ID · 96b1a369-21d3-4c39-bfb3-9799df0f9955
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1169368
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 4, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
- FDA Inspection 1028388 - 2017-07-04
- FDA Inspection 895868 - 2014-07-04
- FDA Inspection 733880 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.